Advanced Robotics
ISSN 0169-1864 · Taylor & Francis · United Kingdom · active 1986–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Advanced Robotics a predatory journal?
Our screening does not flag Advanced Robotics. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Advanced Robotics indexed in Scopus or Web of Science?
Per our venue index, Advanced Robotics appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Advanced Robotics's impact?
Papers in Advanced Robotics are cited about 1.5 times each within two years of publication, and Scimago places it in Q2, with an h-index of 89. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Advanced Robotics open access?
We hold no reliable open-access classification for Advanced Robotics. Check the journal's own site for its access model and any article processing charge.
Similar venues
- Pharmacological ReviewsQ1 · American Society for Pharmacology and Experimental Therapeutics
- Materials Science and Engineering R ReportsQ1 · Elsevier BV
- Physics ReportsQ1 · Elsevier BV
- Drug Resistance UpdatesQ1 · Elsevier BV
- IEEE Transactions on Pattern Analysis and Machine IntelligenceQ1 · IEEE Computer Society
- Robotics and Computer-Integrated ManufacturingQ1 · Elsevier BV